Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease

Background and purpose: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Fatty liver is more common in patients with metabolic syndrome, obese people, and type 2 diabetic individuals. Liver FibroScan is a non-invasive method to evaluate the stiffness and fibrosi...

Full description

Bibliographic Details
Main Authors: Tarang Taghvaei, Hajar Shokri-Afra, Seyed Hassan Emadi Jamali, Hafez Fakheri, Iradj Maleki, Mahboobe Ebrahimi
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences 2023-12-01
Series:Journal of Mazandaran University of Medical Sciences
Subjects:
Online Access:http://jmums.mazums.ac.ir/article-1-19598-en.pdf
_version_ 1827589910985441280
author Tarang Taghvaei
Hajar Shokri-Afra
Seyed Hassan Emadi Jamali
Hafez Fakheri
Iradj Maleki
Mahboobe Ebrahimi
author_facet Tarang Taghvaei
Hajar Shokri-Afra
Seyed Hassan Emadi Jamali
Hafez Fakheri
Iradj Maleki
Mahboobe Ebrahimi
author_sort Tarang Taghvaei
collection DOAJ
description Background and purpose: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Fatty liver is more common in patients with metabolic syndrome, obese people, and type 2 diabetic individuals. Liver FibroScan is a non-invasive method to evaluate the stiffness and fibrosis of the liver. This study aimed to investigate the findings of FibroScan; the level of liver enzymes, triglycerides, and cholesterol; and demographic characteristics of patients with fatty liver. Materials and methods: In this descriptive cross-sectional study, 300 patients referred to the Gastroenterology and Liver Specialist Clinic in Sari City over a year (2017-18). The patients who were diagnosed with fatty liver according to ultrasound results were included after ruling out Wilson's disease, hemochromatosis, viral hepatitis, and autoimmune diseases. Demographic findings and laboratory profiles were recorded from the patients' files. The severity of liver steatosis and fibrosis was determined from FibroScan results. Data were analyzed in SPSS16 software. Mean and standard deviation were used to express the distribution of quantitative variables of the studied groups, and frequency and percentage were utilized to describe qualitative data. To compare quantitative data, an independent t-test was conducted, while qualitative variables were compared using the Chi-Square test. Results: The mean age of patients was obtained at 48.10±13.01 years (range: 18 to 83) and their mean body mass index (BMI) was 30.88±5.47. Gender and smoking were not related to the severity of liver steatosis and fibrosis. Steatosis grade of S3 and fibrosis stage of F1 were found in 58.33% and 62% of patients, respectively. BMI and triglyceride levels had a significant relationship with the severity of liver steatosis (P<0.01). Moreover, liver fibrosis development showed a significant relationship with increasing age, BMI, AST, ALT, ALP, and Chol (P<0.05). Conclusion: The majority of the studied patients were diagnosed with a steatosis grade of S3 and a fibrosis stage of F1. Triglyceride level had a significant relationship with the severity of hepatic steatosis. BMI was related to the severity of steatosis and liver fibrosis; therefore, weight loss and triglyceride control are recommended to reduce steatosis and liver fibrosis, and periodic liver FibroScan is suggested to monitor the changes in liver fibrosis.
first_indexed 2024-03-09T01:08:59Z
format Article
id doaj.art-d02d3a47bb9c47409282b888efe2b53c
institution Directory Open Access Journal
issn 1735-9260
1735-9279
language English
last_indexed 2024-03-09T01:08:59Z
publishDate 2023-12-01
publisher Mazandaran University of Medical Sciences
record_format Article
series Journal of Mazandaran University of Medical Sciences
spelling doaj.art-d02d3a47bb9c47409282b888efe2b53c2023-12-11T09:06:01ZengMazandaran University of Medical SciencesJournal of Mazandaran University of Medical Sciences1735-92601735-92792023-12-01332161170Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver diseaseTarang Taghvaei0Hajar Shokri-Afra1Seyed Hassan Emadi Jamali2Hafez Fakheri3Iradj Maleki4Mahboobe Ebrahimi5 Associate Professor, Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran PhD in Clinical Biochemistry, Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran Assistant Professor, Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran Professor, Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran Professor, Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran Assistant Professor, Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran Background and purpose: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Fatty liver is more common in patients with metabolic syndrome, obese people, and type 2 diabetic individuals. Liver FibroScan is a non-invasive method to evaluate the stiffness and fibrosis of the liver. This study aimed to investigate the findings of FibroScan; the level of liver enzymes, triglycerides, and cholesterol; and demographic characteristics of patients with fatty liver. Materials and methods: In this descriptive cross-sectional study, 300 patients referred to the Gastroenterology and Liver Specialist Clinic in Sari City over a year (2017-18). The patients who were diagnosed with fatty liver according to ultrasound results were included after ruling out Wilson's disease, hemochromatosis, viral hepatitis, and autoimmune diseases. Demographic findings and laboratory profiles were recorded from the patients' files. The severity of liver steatosis and fibrosis was determined from FibroScan results. Data were analyzed in SPSS16 software. Mean and standard deviation were used to express the distribution of quantitative variables of the studied groups, and frequency and percentage were utilized to describe qualitative data. To compare quantitative data, an independent t-test was conducted, while qualitative variables were compared using the Chi-Square test. Results: The mean age of patients was obtained at 48.10±13.01 years (range: 18 to 83) and their mean body mass index (BMI) was 30.88±5.47. Gender and smoking were not related to the severity of liver steatosis and fibrosis. Steatosis grade of S3 and fibrosis stage of F1 were found in 58.33% and 62% of patients, respectively. BMI and triglyceride levels had a significant relationship with the severity of liver steatosis (P<0.01). Moreover, liver fibrosis development showed a significant relationship with increasing age, BMI, AST, ALT, ALP, and Chol (P<0.05). Conclusion: The majority of the studied patients were diagnosed with a steatosis grade of S3 and a fibrosis stage of F1. Triglyceride level had a significant relationship with the severity of hepatic steatosis. BMI was related to the severity of steatosis and liver fibrosis; therefore, weight loss and triglyceride control are recommended to reduce steatosis and liver fibrosis, and periodic liver FibroScan is suggested to monitor the changes in liver fibrosis.http://jmums.mazums.ac.ir/article-1-19598-en.pdffibroscanliver fibrosisliver steatosisnon-alcoholic fatty liver disease (nafld)
spellingShingle Tarang Taghvaei
Hajar Shokri-Afra
Seyed Hassan Emadi Jamali
Hafez Fakheri
Iradj Maleki
Mahboobe Ebrahimi
Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
Journal of Mazandaran University of Medical Sciences
fibroscan
liver fibrosis
liver steatosis
non-alcoholic fatty liver disease (nafld)
title Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
title_full Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
title_fullStr Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
title_full_unstemmed Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
title_short Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
title_sort assessment of laboratory findings and liver elastography in patients with non alcoholic fatty liver disease
topic fibroscan
liver fibrosis
liver steatosis
non-alcoholic fatty liver disease (nafld)
url http://jmums.mazums.ac.ir/article-1-19598-en.pdf
work_keys_str_mv AT tarangtaghvaei assessmentoflaboratoryfindingsandliverelastographyinpatientswithnonalcoholicfattyliverdisease
AT hajarshokriafra assessmentoflaboratoryfindingsandliverelastographyinpatientswithnonalcoholicfattyliverdisease
AT seyedhassanemadijamali assessmentoflaboratoryfindingsandliverelastographyinpatientswithnonalcoholicfattyliverdisease
AT hafezfakheri assessmentoflaboratoryfindingsandliverelastographyinpatientswithnonalcoholicfattyliverdisease
AT iradjmaleki assessmentoflaboratoryfindingsandliverelastographyinpatientswithnonalcoholicfattyliverdisease
AT mahboobeebrahimi assessmentoflaboratoryfindingsandliverelastographyinpatientswithnonalcoholicfattyliverdisease